|
Volumn 52, Issue 4, 1999, Pages 682-685
|
Placebo-controlled studies in neurology: Where do they stop?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
BENZODIAZEPINE DERIVATIVE;
OXCARBAZEPINE;
PLACEBO;
ANTICONVULSANT THERAPY;
CLINICAL PHARMACOLOGY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PATIENT CARE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
HUMANS;
NEUROLOGY;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0033541095
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (43)
|
References (17)
|